107 related articles for article (PubMed ID: 7976501)
1. Upregulation of c-fos protooncogene expression in pagetic osteoclasts.
Hoyland J; Sharpe PT
J Bone Miner Res; 1994 Aug; 9(8):1191-4. PubMed ID: 7976501
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease.
Hoyland JA; Freemont AJ; Sharpe PT
J Bone Miner Res; 1994 Jan; 9(1):75-80. PubMed ID: 8154312
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone.
Naot D; Bava U; Matthews B; Callon KE; Gamble GD; Black M; Song S; Pitto RP; Cundy T; Cornish J; Reid IR
J Bone Miner Res; 2007 Feb; 22(2):298-309. PubMed ID: 17129176
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic gene expression in Paget's disease: a possible role for Bcl-2.
Brandwood CP; Hoyland JA; Hillarby MC; Berry JL; Davies M; Selby PL; Mee AP
J Pathol; 2003 Nov; 201(3):504-12. PubMed ID: 14595764
[TBL] [Abstract][Full Text] [Related]
5. Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.
Sunters A; McCluskey J; Grigoriadis AE
Dev Genet; 1998; 22(4):386-97. PubMed ID: 9664690
[TBL] [Abstract][Full Text] [Related]
6. Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice.
Kurihara N; Zhou H; Reddy SV; Garcia Palacios V; Subler MA; Dempster DW; Windle JJ; Roodman GD
J Bone Miner Res; 2006 Mar; 21(3):446-55. PubMed ID: 16491293
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia.
Candeliere GA; Glorieux FH; Prud'homme J; St-Arnaud R
N Engl J Med; 1995 Jun; 332(23):1546-51. PubMed ID: 7739708
[TBL] [Abstract][Full Text] [Related]
8. c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos.
Wang ZQ; Liang J; Schellander K; Wagner EF; Grigoriadis AE
Cancer Res; 1995 Dec; 55(24):6244-51. PubMed ID: 8521421
[TBL] [Abstract][Full Text] [Related]
9. CSF-1 induces fos gene transcription and activates the transcription factor Elk-1 in mature osteoclasts.
Yao GQ; Itokawa T; Paliwal I; Insogna K
Calcif Tissue Int; 2005 May; 76(5):371-8. PubMed ID: 15812575
[TBL] [Abstract][Full Text] [Related]
10. A putative role for c-Fos in the pathophysiology of Paget's disease.
Beedles KE; Sharpe PT; Wagner EF; Grigoriadis AE
J Bone Miner Res; 1999 Oct; 14 Suppl 2():21-8. PubMed ID: 10510209
[TBL] [Abstract][Full Text] [Related]
11. [Viral origin of Paget's disease of bone?].
Basle MF; Chappard D; Rebel A
Presse Med; 1996 Jan; 25(3):113-8. PubMed ID: 8746085
[TBL] [Abstract][Full Text] [Related]
12. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
13. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone.
Teramachi J; Zhou H; Subler MA; Kitagawa Y; Galson DL; Dempster DW; Windle JJ; Kurihara N; Roodman GD
J Bone Miner Res; 2014 Jun; 29(6):1456-65. PubMed ID: 24339057
[TBL] [Abstract][Full Text] [Related]
14. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
Matsuo K; Owens JM; Tonko M; Elliott C; Chambers TJ; Wagner EF
Nat Genet; 2000 Feb; 24(2):184-7. PubMed ID: 10655067
[TBL] [Abstract][Full Text] [Related]
15. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
[TBL] [Abstract][Full Text] [Related]
16. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.
Takayanagi H; Kim S; Matsuo K; Suzuki H; Suzuki T; Sato K; Yokochi T; Oda H; Nakamura K; Ida N; Wagner EF; Taniguchi T
Nature; 2002 Apr; 416(6882):744-9. PubMed ID: 11961557
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of modern research technics to the identification of a virus in Paget's disease of bone].
Rebel A; Basle MF; Fournier JG; Russel WC
Bull Assoc Anat (Nancy); 1986 Jun; 70(209):15-20. PubMed ID: 3620721
[TBL] [Abstract][Full Text] [Related]
20. The Fos-related antigen Fra-1 is an activator of bone matrix formation.
Eferl R; Hoebertz A; Schilling AF; Rath M; Karreth F; Kenner L; Amling M; Wagner EF
EMBO J; 2004 Jul; 23(14):2789-99. PubMed ID: 15229648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
